Advertisement
FEMY vs OM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEMY is a StrongBuy and OM is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FEMY’s FA Score shows that 1 FA rating(s) are green whileOM’s FA Score has 1 green FA rating(s).
- FEMY’s FA Score: 1 green, 4 red.
- OM’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FEMY’s TA Score shows that 4 TA indicator(s) are bullish while OM’s TA Score has 1 bullish TA indicator(s).
- FEMY’s TA Score: 4 bullish, 3 bearish.
- OM’s TA Score: 1 bullish, 4 bearish.
Price Growth
FEMY (@Pharmaceuticals: Other) experienced а -14.95% price change this week, while OM (@Medical/Nursing Services) price change was -14.17% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.66%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.62%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -16.57%.
Reported Earning Dates
FEMY is expected to report earnings on Aug 12, 2026.
OM is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.39% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+7.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| FEMY | OM | FEMY / OM | |
| Capitalization | 10.4M | 81M | 13% |
| EBITDA | -9.44M | -56.43M | 17% |
| Gain YTD | -69.889 | 17.520 | -399% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 2.38M | 118M | 2% |
| Total Cash | N/A | 157M | - |
| Total Debt | 4.73M | 102M | 5% |
OM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 63 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| FEMY | OM | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | N/A |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| MACD ODDS (%) | 1 day ago 80% | 1 day ago 86% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 88% |
| Advances ODDS (%) | N/A | N/A |
| Declines ODDS (%) | 19 days ago 90% | 1 day ago 89% |
| BollingerBands ODDS (%) | 5 days ago 88% | N/A |
| Aroon ODDS (%) | 1 day ago 90% | N/A |
Advertisement
FEMY and
Correlation & Price change
A.I.dvisor tells us that FEMY and OFIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OFIX's prices will move in lockstep.
| Ticker / NAME | Correlation To FEMY | 1D Price Change % | ||
|---|---|---|---|---|
| FEMY | 100% | -13.03% | ||
| OFIX - FEMY | 30% Poorly correlated | +1.38% | ||
| CSTL - FEMY | 30% Poorly correlated | -3.12% | ||
| LUCD - FEMY | 30% Poorly correlated | -0.89% | ||
| OM - FEMY | 29% Poorly correlated | -1.58% | ||
| GH - FEMY | 29% Poorly correlated | -1.03% | ||
More | ||||
OM and
Correlation & Price change
A.I.dvisor indicates that over the last year, OM has been loosely correlated with COO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OM jumps, then COO could also see price increases.